Search

Author/Creator Perry, Daniel J.

1. Genetic risk analysis of a patient with fulminant autoimmune type 1 diabetes mellitus secondary to combination ipilimumab and nivolumab immunotherapy. Issue 1 (20th December 2016)

Authors:
Lowe, Jared R.; Perry, Daniel J.; Salama, April K. S.; Mathews, Clayton E.; Moss, Larry G.; Hanks, Brent A.
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 4:Issue 1(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Guidelines for standardizing T‐cell cytometry assays to link biomarkers, mechanisms, and disease outcomes in type 1 diabetes. Issue 3 (28th January 2022)

Authors:
Yang, Jennie H. M.; Ward‐Hartstonge, Kirsten A.; Perry, Daniel J.; Blanchfield, J. Lori; Posgai, Amanda L.; Wiedeman, Alice E.; Diggins, Kirsten; Rahman, Adeeb; Tree, Timothy I. M.; Brusko, Todd M.; Levings, Megan K.; James, Eddie A.; Kent, Sally C.; Speake, Cate; Homann, Dirk; Long, S. Alice
Journal:
European journal of immunology
Issue:
Volume 52:Issue 3(2022)
Page Start:
372
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Innate inflammation drives NK cell activation to impair Treg activity. Issue 108 (March 2020)

Authors:
Dean, Joseph W.; Peters, Leeana D.; Fuhrman, Christopher A.; Seay, Howard R.; Posgai, Amanda L.; Stimpson, Scott E.; Brusko, Maigan A.; Perry, Daniel J.; Yeh, Wen-I.; Newby, Brittney N.; Haller, Michael J.; Muir, Andrew B.; Atkinson, Mark A.; Mathews, Clayton E.; Brusko, Todd M.
Journal:
Journal of autoimmunity
Issue:
Issue 108(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗